4 results for "weight-loss"

Researchers propose activating GIP and glucagon receptors achieves weight loss comparable to GLP-1 drugs without nausea. A paradigm shift for 2026 that could be

Pioneering GLP-1 researchers propose an experimental drug activating GIP and glucagon receptors, achieving comparable weight loss in animals without common gast

FDA requested additional liver injury data on a recently approved obesity pill. GLP-1 medication users need to implement rigorous liver monitoring protocols, es

Generic GLP-1 drugs captured 33% of India's market after patent expiration, signaling a watershed moment for obesity treatment access. Patients gain affordable